Which is the best advanced MR imaging protocol for predicting recurrent metastatic brain tumor following gamma-knife

Myeong Ju Koh1, Ho Sung Kim, Choong Gon Choi

  • 1Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, 86 Asanbyeongwon-Gil, Songpa-Gu, Seoul, 138-736, South Korea.

Neuroradiology
|January 17, 2015
PubMed
Abstract

Insights

Adding advanced MR perfusion imaging, such as dynamic susceptibility contrast (DSC) or dynamic contrast-enhanced (DCE) imaging, to diffusion-weighted imaging (DWI) significantly improves the prediction of recurrent metastatic brain tumors after gamma-knife radiosurgery (GKRS). The choice between DSC and DCE does not impact diagnostic performance.

Area of Science:

  • Radiology
  • Oncology
  • Medical Imaging

Background:

  • Dynamic contrast-enhanced (DCE) MR imaging offers high spatial resolution for characterizing heterogeneous tumor microenvironments.
  • Predicting recurrent metastatic brain tumors after gamma-knife radiosurgery (GKRS) is crucial for patient management.

Purpose of the Study:

  • To determine the optimal advanced MR imaging protocol for predicting recurrent metastatic brain tumors post-GKRS.
  • To compare the efficacy of different MR perfusion methods when added to diffusion-weighted imaging (DWI).

Main Methods:

  • Seventy-two patients with post-GKRS metastatic brain tumors were analyzed.
  • Normalized cerebral blood volume (nCBV) from dynamic susceptibility contrast (DSC) and initial area under the curve (IAUC) from DCE imaging were calculated.
  • Area under the receiver operating characteristic curve (AUC) and interreader agreement were assessed.

Main Results:

  • Adding DCE imaging to DWI significantly improved AUC for differentiating tumor recurrence (0.79-0.95 for reader 1, 0.80-0.96 for reader 2).
  • No significant difference in AUC was observed between DWI combined with DSC versus DWI combined with DCE.
  • DWI and DCE combination achieved high sensitivity (86.7-90.0%) and specificity (85.7-88.1%).

Conclusions:

  • Perfusion MR imaging, when added to DWI, substantially enhances the prediction of recurrent metastatic tumors.
  • The diagnostic performance for predicting recurrence is not significantly influenced by the choice between DSC and DCE MR perfusion techniques.

Related Concept Videos